Abstract
P-161 A phase I-trial assessing several schedules of Oral S-1 combined with fixed doses of Oxaliplatin and Irinotecan in patients with advanced or metastatic digestive adenocarcinoma as first- or second-line treatment
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have